Slingshot members are tracking this event:
PRM-151 (pentraxin-2) Advances into Phase 2 Stage for Myelofibrosis - Study to Complete in 2017
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jun 25, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Prm-151, Pentraxin-2, Phase 2 Trial, Myelofibrosis